News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
- Chief Compliance Officer and VP of Legal Affairs, Arrow Electronics
By Kyle Brasseur2023-10-27T16:25:00
It’s no secret the U.S. healthcare competition system has significant flaws. Where the debate exists is in determining the source of the issues and how to fix them, according to a senior Department of Justice (DOJ) official.
Deputy Assistant Attorney General Andrew Forman of the DOJ’s Antitrust Division said in a speech delivered Thursday that while he believes antitrust enforcement is a critical part of the solution to fix the country’s healthcare competition woes, “It is not a magic potion to cure all the competitive ills of the healthcare industry.” He noted in his remarks how of the more than 3,000 comments the agency’s recent draft merger guidelines received, some of the most striking regarded personal comments around healthcare from workers in the space, patients, and companies.
“[T]here is little doubt that key aspects of competition in the healthcare industry are broken,” Forman said. “The system has real competitive problems, and these problems impact real people in real ways.”
THIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.
News and analysis for the well-informed compliance or audit exec. Select an option and click continue.
Annual Membership $499 Value offer
Full price one year membership with auto-renewal.
Membership $599
One-year only, no auto-renewal.
2023-12-18T20:48:00Z By Kyle Brasseur
A long-running initiative by the Department of Justice and Federal Trade Commission to modernize their joint merger guidelines reached its conclusion, following tens of thousands of public comments.
2023-09-21T20:38:00Z By Kyle Brasseur
The Department of Justice is gearing up to provide more guidance on voluntary self-disclosures in the mergers and acquisitions space and the role compliance should play.
2023-07-19T21:39:00Z By Kyle Brasseur
New draft merger guidance put forward by the Department of Justice and Federal Trade Commission continues the agencies’ joint mission to modernize antitrust enforcement.
2024-10-22T21:18:00Z By Adrianne Appel
Precision Toxicology has agreed to pay $27 million to settle allegations first brought by whistleblowers in three cases, that the company billed the federal government for unnecessary drug tests and paid kickbacks to doctors, the Department of Justice (DOJ) said.
2024-10-22T16:08:00Z By Aaron Nicodemus
Fund management company WisdomTree will pay $4 million to settle allegations by the Securities and Exchange Commission that it improperly invested in fossil fuel and tobacco companies in environmental, social and governance (ESG) funds despite promising to avoid them.
2024-10-18T18:10:00Z By Adrianne Appel
A Vietnamese alcohol company has agreed to pay $860,000 to settle allegations by the Office of Foreign Assets Control (OFAC) that its business with North Korea involved U.S. financial institutions.
Site powered by Webvision Cloud